Domvanalimab
Showing 1 - 13 of 13
Hepatobiliary Cancer, Liver Cancer Trial (Zimberelimab, Domvanalimab)
Not yet recruiting
- Hepatobiliary Cancer
- Liver Cancer
- Zimberelimab
- Domvanalimab
- (no location specified)
Feb 2, 2023
Melanoma Trial in Pittsburgh (Zimberelimab, Domvanalimab)
Recruiting
- Melanoma
- Zimberelimab
- Domvanalimab
-
Pittsburgh, PennsylvaniaUPMC Hillman Cancer Center
Apr 11, 2022
NSCLC Trial (Zimberelimab, Domvanalimab, Pembrolizumab)
Not yet recruiting
- Non-small Cell Lung Cancer
- Zimberelimab
- +7 more
- (no location specified)
Aug 12, 2022
Non Small Cell Lung Cancer, Non-small Cell Carcinoma, NSCLC Trial in Saint Louis (Zimberelimab, Domvanalimab, Etrumadenant)
Recruiting
- Non Small Cell Lung Cancer
- +2 more
- Zimberelimab
- +2 more
-
Saint Louis, MissouriWashington University School of Medicine
Aug 8, 2022
Urothelial Bladder Carcinoma Trial in Spain (Sacituzumab govitecan, Zimberelimab, Domvanalimab)
Not yet recruiting
- Urothelial Bladder Carcinoma
- Sacituzumab govitecan
- +2 more
-
Santiago De Compostela, A Coruña, Spain
- +9 more
Nov 14, 2023
Advanced Upper Gastrointestinal Tract Adenocarcinoma Trial in United States (Zimberelimab, Domvanalimab, Nivolumab)
Recruiting
- Advanced Upper Gastrointestinal Tract Adenocarcinoma
- Zimberelimab
- +6 more
-
Hot Springs, Arkansas
- +11 more
Dec 6, 2022
Pancreatic Cancer, Adenocarcinoma of the Pancreas, Squamous Cell Carcinoma of Pancreas Trial in Boston (ZIMBERELIMAB,
Recruiting
- Pancreatic Cancer
- +3 more
- ZIMBERELIMAB
- +3 more
-
Boston, MassachusettsDana Farber Cancer Institute
Jan 9, 2023
Lung Cancer, Advanced or Metastatic Non-Small-Cell Lung Cancer Trial (Zimberelimab (ZIM), Domvanalimab (DOM), Sacituzumab
Not yet recruiting
- Lung Cancer
- Advanced or Metastatic Non-Small-Cell Lung Cancer
- Zimberelimab (ZIM)
- +9 more
- (no location specified)
Nov 21, 2022
Advanced NSCLC Trial in Spokane (Zimberelimab, Domvanalimab, Quemliclustat)
Recruiting
- Advanced Non-Small Cell Lung Cancer
- Zimberelimab
- +4 more
-
Spokane, WashingtonMedical Oncology Associates
Jan 5, 2023
Gastrointestinal Tract Malignancies Trial in Sarasota, Nashville (Zimberelimab, Domvanalimab, Fluorouracil)
Recruiting
- Gastrointestinal Tract Malignancies
- Zimberelimab
- +5 more
-
Phoenix, Arizona
- +26 more
Jan 20, 2023
Metastatic Urothelial Cancer Trial in France, United States (Sacituzumab Govitecan-hziy, Pembrolizumab, Cisplatin)
Recruiting
- Metastatic Urothelial Cancer
- Sacituzumab Govitecan-hziy
- +7 more
-
Tucson, Arizona
- +44 more
Jan 9, 2023
Non Small Cell Lung Cancer, Nonsquamous Non Small Cell Lung Cancer, Squamous Non-small-cell Lung Cancer Trial in Worldwide
Recruiting
- Non Small Cell Lung Cancer
- +3 more
- Zimberelimab
- +4 more
-
Dhaka, Bangladesh
- +139 more
Dec 8, 2022